GlassScriptPhysician profile
Usman Ahmad
NPI 1245494392
$6,397.84
in general payments reported to CMS, 2019-2025
37 companies · $2,515 in 2025
The $2,515 reported for 2025 was more than what 84% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $668 · 2020: $159 · 2021: $143 · 2022: $436 · 2023: $1,014 · 2024: $1,462 · 2025: $2,515.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,962 · Education: $29.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,961.71 |
| Education | $29.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,278.49 | 2019-2025 | Rinvoq, Linzess, Creon |
| Janssen Biotech, INC. | $881.35 | 2019-2025 | Tremfya, Stelara, Simponi Aria |
| Boston Scientific Corporation | $675.77 | 2024-2025 | Exalt Model D, Axios, X-Tack Endoscopic Helix Tacking System |
| Takeda Pharmaceuticals U.S.A., INC. | $652.00 | 2019-2025 | Entyvio, Eohilia, Gattex |
| Regeneron Healthcare Solutions, INC. | $445.90 | 2023-2025 | Dupixent |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $274.97 | 2019-2025 | Trulance, Relistor, Xifaxan |
| Phathom Pharmaceuticals, INC. | $193.65 | 2024-2025 | Voquezna |
| Gilead Sciences, INC. | $185.45 | 2020-2025 | |
| Biosense Webster, INC. | $146.75 | 2025 | Carto 3 |
| Pfizer INC. | $143.93 | 2019-2025 | |
| Celgene Corporation | $132.56 | 2023-2024 | Zeposia |
| Amarin Pharma, INC. | $124.94 | 2019 | |
| Qol Medical, LLC | $121.38 | 2024-2025 | Sucraid, Sucraid |
| Conmed Corporation | $114.98 | 2021 | |
| Ardelyx, INC. | $99.63 | 2023-2025 | Ibsrela |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $92.31 | 2019-2025 | Sutab, Suflave |
| Lilly USA, LLC | $91.25 | 2024-2025 | Omvoh |
| Cumberland Pharmaceuticals, INC. | $90.85 | 2019 | |
| Aimmune Therapeutics, INC. | $77.54 | 2024-2025 | Zenpep, Vowst |
| Vivus LLC | $76.33 | 2023-2025 | Pancreaze |
| Merck Sharp & Dohme LLC | $74.89 | 2019-2023 | Dificid |
| Nestle Healthcare Nutrition INC. | $57.11 | 2022-2023 | |
| Genzyme Corporation | $38.47 | 2024 | |
| Daiichi Sankyo INC. | $38.42 | 2019-2020 | |
| Madrigal Pharmaceuticals | $37.81 | 2025 | Rezdiffra |
| Allergan, INC. | $32.84 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $30.80 | 2019-2024 | |
| Ipsen Biopharmaceuticals, INC | $29.35 | 2024 | Iqirvo |
| Ferring Pharmaceuticals INC. | $24.82 | 2023 | Rebyota |
| Redhill Biopharma INC. | $21.62 | 2022 | |
| Celltrion USA INC. | $20.01 | 2024 | Zymfentra |
| Exact Sciences Corporation | $18.39 | 2023 | Cologuard Collection Kit |
| Echosens North America, INC. | $16.48 | 2024 | Fibroscan |
| Medtronic, INC. | $14.79 | 2022 | |
| Ucb, INC. | $14.50 | 2020 | |
| Cook Medical LLC | $14.05 | 2025 | Echotip Insight |
| Biocon Biologics INC | $13.46 | 2025 | Yesintek |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Usman Ahmad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.